November 15, 2016
TraceLink Inc., the World’s Largest Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced support of the newly published GS1 US guideline, “Applying GS1 Standards for DSCSA and Traceability (R1.2),” to help the pharmaceutical industry prepare for Drug Supply Chain Security Act (DSCSA) serialization requirements. Elizabeth Waldorf, Director, Global Traceability and Standards at TraceLink, was one of the two technical editors of the new GS1 US guideline.
The TraceLink Life Sciences Cloud supports the use of GS1 Electronic Product Code Information Service (EPCIS) between internal systems and trade partners at the packaging line, enterprise, and network levels, offering flexible integration and data translation and transport capabilities. Through TraceLink’s proven network solution, customers can seamlessly exchange both EPCIS data, HDA ASN and other data formats between both their own systems and with trade partners regardless of format discrepancies or differing transport preferences, allowing them to seamlessly achieve both business efficiencies and partner interoperability. The adoption of the EPCIS standard in the Life Sciences Cloud now lays a secure foundation for the efficient exchange of serialization data and events to support DSCSA serialization and verification requirements across the supply chain.
“The release of this new guideline is the result of a two-year collaboration and commitment from the members of the GS1 Healthcare US Secure Supply Chain Workgroup. TraceLink played a critical role in helping to define this latest release and we are grateful for the involvement by Elizabeth Waldorf of TraceLink, who was a key contributor as the technical editor of the new GS1 US 1.2 DSCSA and Traceability guideline,” said Peter Sturtevant, Senior Director, Industry Development, Pharmaceuticals, GS1 US. “We look forward to continuing our work with all of the Workgroup members to determine how the EPCIS standards can continue to be applied to best support DSCSA serialization and traceability.”
“TraceLink’s long-standing support of EPCIS and steadfast relationship with GS1 US spans across many years and global markets, due to our shared alignment on ensuring that the pharmaceutical supply chain can exchange and manage the massive volume of data and transactions expected to occur as global markets transition to serialization,” said Shabbir Dahod, president and CEO of TraceLink. “We’re proud of our ongoing alliance with GS1 US and look forward to optimizing the Life Sciences Cloud with this latest GS1 US 1.2 DSCSA and Traceability guideline to continue interoperability with GS1 Standards.”
With four active members of the GS1 Healthcare US Secure Supply Chain Workgroup, TraceLink leaders began the partnership with GS1 over a decade ago, delivering on a series of industry-first EPCIS and GS1 milestones, including: